Discovering Effective Treatments & A Cure for Fragile X Syndrome

Your support enables FRAXA Research Foundation to fund groundbreaking research and life-changing clinical trials.

Discovering Effective Treatments & A Cure for Fragile X Syndrome

How Does FRAXA Help?

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Every member of our staff and Board of Directors is a parent of one or more children with Fragile X, making our commitment to this cause deeply personal.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

What is Fragile X Syndrome?

Fragile X syndrome (FXS) is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4,000 boys and 1 in 8,000 girls worldwide.

Fragile X syndrome occurs when a single gene on the X chromosome shuts down. This gene makes a protein needed for normal brain development. In FXS it does not work properly, the protein is not made, and the brain does not develop as it should.

Symptoms of Fragile X syndrome can include developmental delays, social anxiety, and learning disabilities, which vary between individuals.

The Latest from FRAXA

Digital illustration featuring Twitch streamer Zae as an animated character with Pokémon Plusle and Minun beside the FRAXA logo.

Pokémon Tournament Twitch Stream Raises $2,100 for FRAXA

November 5, 2025

Twitch streamer Zae hosted a Pokémon charity tournament that raised $2,100 for the FRAXA Research Foundation and Fragile X research — uniting a global community through gaming for a cause.

Read More »
Ziyuan Guo, PhD, and Lu Lu, PhD, standing together in a research lab with laboratory equipment in the background.

METTL3 Inhibitors and FDA-Approved Drugs in a New Fragile X Treatment Strategy Using Organoids

November 4, 2025

Researchers are testing METTL3 inhibitors and FDA-approved drugs in brain organoids to explore new pathways for treating Fragile X and related disorders.

Read More »

Celebrating 20 Years of the Fragile X Poker Run in Sparta, NC

October 30, 2025

The 20th Annual Fragile X Poker Run in Sparta, NC celebrated two decades of community, music, and fundraising for Fragile X research.

Read More »
No event found!

FRAXA's Impact to Date

FRAXA's Interactive Fragile X Timeline

Explore 30 years of outstanding Fragile X research.

$37.8M

Direct Investment in Fragile X Research

47

Teams Actively Researching Fragile X Syndrome

33

Pharmaceutical and Biomedical Partners

656

Fragile X Research Grants Awarded